Lead-DossierGelandet19:48

A novel PD-1 x VEGF bispecific antibody program for patients with cancer

symbioticclinicaltrials.com · Entdeckt vor 2 Std.

Zusammenfassung

View information on a series of oncology clinical trials evaluating a bispecific antibody that targets both PD-1 and VEGF